EP1179002A4 - Methods using mechanisms of action of aroa - Google Patents

Methods using mechanisms of action of aroa

Info

Publication number
EP1179002A4
EP1179002A4 EP00928848A EP00928848A EP1179002A4 EP 1179002 A4 EP1179002 A4 EP 1179002A4 EP 00928848 A EP00928848 A EP 00928848A EP 00928848 A EP00928848 A EP 00928848A EP 1179002 A4 EP1179002 A4 EP 1179002A4
Authority
EP
European Patent Office
Prior art keywords
aroa
mechanisms
action
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00928848A
Other languages
German (de)
French (fr)
Other versions
EP1179002A1 (en
Inventor
James R Brown
Alison F Chalker
Lisa K Katz
Marie Jean Mazzulla
David J Payne
Christopher M Traini
Wengsheng Du
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of EP1179002A1 publication Critical patent/EP1179002A1/en
Publication of EP1179002A4 publication Critical patent/EP1179002A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
EP00928848A 1999-05-07 2000-05-04 Methods using mechanisms of action of aroa Withdrawn EP1179002A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13307099P 1999-05-07 1999-05-07
US133070P 1999-05-07
PCT/US2000/012251 WO2000068243A1 (en) 1999-05-07 2000-05-04 Methods using mechanisms of action of aroa

Publications (2)

Publication Number Publication Date
EP1179002A1 EP1179002A1 (en) 2002-02-13
EP1179002A4 true EP1179002A4 (en) 2002-08-07

Family

ID=22456875

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00928848A Withdrawn EP1179002A4 (en) 1999-05-07 2000-05-04 Methods using mechanisms of action of aroa

Country Status (3)

Country Link
EP (1) EP1179002A4 (en)
JP (1) JP2002543776A (en)
WO (1) WO2000068243A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003046183A2 (en) * 2001-11-23 2003-06-05 Université de Montréal Streptococcus suis avirulent vaccine and uses in antibiotic design
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854188A2 (en) * 1997-01-21 1998-07-22 Smithkline Beecham Streptococcus pneumoniae aroE polypeptides and polynucleotides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883239A (en) * 1997-07-18 1999-03-16 Smithkline Beecham Corporation aroA

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854188A2 (en) * 1997-01-21 1998-07-22 Smithkline Beecham Streptococcus pneumoniae aroE polypeptides and polynucleotides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DU W ET AL: "CHARACTERIZATION OF 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE FROM STREPTOCOCCUS PNEUMONIAE", ABSTRACT OF PAPERS AMERICAN CHEMICAL SOCIETY, vol. 217, no. 1-2, 1999, pages MEDI190, XP000937801 *
See also references of WO0068243A1 *

Also Published As

Publication number Publication date
EP1179002A1 (en) 2002-02-13
JP2002543776A (en) 2002-12-24
WO2000068243A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
PT2759291T (en) Therapeutic microfoams
GB0021259D0 (en) Water treatment
TW524114U (en) Massager
GB9930570D0 (en) Therapy
GB9907243D0 (en) Therapy
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB9910377D0 (en) Tissue engineering
GB9929694D0 (en) Water treatment
PL350963A1 (en) Use of arylalkanoylpyridazines
EP1179002A4 (en) Methods using mechanisms of action of aroa
EP1194439A4 (en) Human eag2
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB9821179D0 (en) Therapeutic use
GB9911238D0 (en) Therapeutic use
GB9812664D0 (en) Therapeutic use
AU141196S (en) Tissue
PL330386A1 (en) Bathtub
TW387252U (en) Massager
CA84178S (en) Whirlpool
CA84085S (en) Whirlpool
GB9910667D0 (en) New use of citreamicins
GB9903473D0 (en) Therapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020626

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITHKLINE BEECHAM CORPORATION

Owner name: SMITHKLINE BEECHAM PLC

17Q First examination report despatched

Effective date: 20050225

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050708